Canine Cushing's Case Files: The ins and outs of detection and treatment—Case file: 5 Questions Veterinarians Ask (Sponsored by Dechra Veterinary Products)
Case file: 5 questions veterinarians ask the Dechra Veterinary Products Technical Services Team
Diagnosing canine hyperadrenocorticism can be fairly straightforward, based on history and clinical signs, along with the results of diagnostic tests that are readily available to practitioners. Once a diagnosis of pituitary- or adrenal-dependent hyperadrenocorticism is made, VETORYL® (trilostane) Capsules are the only FDA-approved drug indicated for medical treatment of either condition. VETORYL Capsules are backed by a company with a veterinary technical services team ready to answer your questions.
In this case file, the Dechra Veterinary Products Technical Services Team answers five questions they are frequently asked about canine hyperadrenocorticism and VETORYL Capsules. When you identify canine Cushing's cases and you have questions about this treatment, contact the team who wants to help you successfully manage your patients.Q: What sizes of VETORYL Capsules are available, and is an exact dose required when starting treatment for canine hyperadrenocorticism?
Q: What is the recommended monitoring protocol, and what information should be obtained from the owner at each recheck appointment?
We cannot overemphasize the importance of talking with the owner at each recheck appointment about how the dog is doing at home. Specifically, ask:
This information is critical when interpreting the results of the ACTH stimulation and other biochemical tests. Dechra Veterinary Products encourages veterinarians to contact the Veterinary Technical Services Team if assistance is needed in interpreting test results.